Skip to main content

Table 4 Base-case results from cost-effectiveness analysis of expanding HepB vaccination coverage vs current coverage (June 2019)

From: Cost-effectiveness analysis of current non-mandatory hepatitis B vaccination coverage vs expanding coverage among healthcare workers in Ethiopia

Strategy

Life Years

Cost

Incremental LYs

Incremental cost

ICER

Current HepB vaccination coverage (14%)

28.54

29.99

–

–

–

Expanding HepB vaccination coverage (80%)

28.62

28.67

0.08

USD-1.32

− 16.5

  1. ICER incremental cost-effectiveness ratio, USD United States Dollar